/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments

Rx/Medicines

Topic

Latest Stories

OD
12.20.23, 2:17 PM EST on neoscope
Thousands of People Have Reportedly Overdosed on Ozempic
Losing It
12.2.23, 7:30 AM EST on neoscope
Pfizer Cancels New Weight Loss Pill After Patients Experience Serious Side Effects
Losses and Gains
10.12.23, 10:37 AM EDT on neoscope
Woman Sues to Get Wegovy Covered by Her Health Insurance
Wally World
10.8.23, 6:30 AM EDT on neoscope
Walmart Spies on Ozempic Patients' Shopping Habits, Finds They're Buying Less Food
Snacko Killer
10.6.23, 10:35 AM EDT on neoscope
Snack Food Investors Concerned About the Rise of Semaglutide
Cheez-Its, To You...
10.3.23, 1:26 PM EDT on neoscope
Snack Food CEO Vows to Battle Ozempic
No Guts, No Glory
9.28.23, 2:58 PM EDT on neoscope
The FDA Says Ozempic Might Block Your Intestines
Don't Be A Pill
9.27.23, 1:28 PM EDT on neoscope
Scientists Intrigued by Drug That Mimics the Effects of Exercise in Mice
Needlehead Ned
8.24.23, 12:09 PM EDT on neoscope
Google Seems to Be Running a Lot of Ads for Black Market Semaglutide
Pharma Foolishness
Updated 8.9.23, 1:49 PM EDT on neoscope
Shocker: Pharma Companies Are Behind the Adderall Shortage, Feds Say
Insure and Inject
8.9.23, 1:40 PM EDT on neoscope
Wegovy Trial Shows Incredible Results for Heart Health
Uplifting
Updated 6.15.23, 11:37 AM EDT on neoscope
FDA Approves First Erectile Dysfunction Gel That Doesn't Require a Prescription
  • Previous
  • 1
  • ...
  • 15
  • 16
  • 17
  • 18
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.